Literature DB >> 32668198

The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

Emma S Winkler1, Swathi Shrihari2, Barry L Hykes3, Scott A Handley3, Prabhakar S Andhey4, Yan-Jang S Huang5, Amanda Swain4, Lindsay Droit3, Kranthi K Chebrolu6, Matthias Mack7, Dana L Vanlandingham5, Larissa B Thackray2, Marina Cella4, Marco Colonna4, Maxim N Artyomov4, Thaddeus S Stappenbeck8, Michael S Diamond9.   

Abstract

Chikungunya virus (CHIKV), an emerging alphavirus, has infected millions of people. However, the factors modulating disease outcome remain poorly understood. Here, we show in germ-free mice or in oral antibiotic-treated conventionally housed mice with depleted intestinal microbiomes that greater CHIKV infection and spread occurs within 1 day of virus inoculation. Alteration of the microbiome alters TLR7-MyD88 signaling in plasmacytoid dendritic cells (pDCs) and blunts systemic production of type I interferon (IFN). Consequently, circulating monocytes express fewer IFN-stimulated genes and become permissive for CHIKV infection. Reconstitution with a single bacterial species, Clostridium scindens, or its derived metabolite, the secondary bile acid deoxycholic acid, can restore pDC- and MyD88-dependent type I IFN responses to restrict systemic CHIKV infection and transmission back to vector mosquitoes. Thus, symbiotic intestinal bacteria modulate antiviral immunity and levels of circulating alphaviruses within hours of infection through a bile acid-pDC-IFN signaling axis, which affects viremia, dissemination, and potentially transmission.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clostridium; alphavirus; bile acid; chikungunya; interferon; microbiome; monocyte; pathogenesis; plasmacytoid dendritic cell

Mesh:

Substances:

Year:  2020        PMID: 32668198      PMCID: PMC7483520          DOI: 10.1016/j.cell.2020.06.029

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  95 in total

1.  The microbial metabolite desaminotyrosine protects from influenza through type I interferon.

Authors:  Ashley L Steed; George P Christophi; Gerard E Kaiko; Lulu Sun; Victoria M Goodwin; Umang Jain; Ekaterina Esaulova; Maxim N Artyomov; David J Morales; Michael J Holtzman; Adrianus C M Boon; Deborah J Lenschow; Thaddeus S Stappenbeck
Journal:  Science       Date:  2017-08-04       Impact factor: 47.728

2.  Inhibitory effects of bile acids and synthetic farnesoid X receptor agonists on rotavirus replication.

Authors:  Yunjeong Kim; Kyeong-Ok Chang
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Application of a Nonpaper Based Matrix to Preserve Chikungunya Virus Infectivity at Ambient Temperature.

Authors:  So Lee Park; Yan-Jang S Huang; Stephen Higgs; Dana L Vanlandingham
Journal:  Vector Borne Zoonotic Dis       Date:  2018-03-15       Impact factor: 2.133

4.  Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.

Authors:  Megan T Baldridge; Timothy J Nice; Broc T McCune; Christine C Yokoyama; Amal Kambal; Michael Wheadon; Michael S Diamond; Yulia Ivanova; Maxim Artyomov; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

5.  Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies.

Authors:  Konstantin Tsetsarkin; Stephen Higgs; Charles E McGee; Xavier De Lamballerie; Remi N Charrel; Dana L Vanlandingham
Journal:  Vector Borne Zoonotic Dis       Date:  2006       Impact factor: 2.133

6.  Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.

Authors:  Elisabeth Kamphuis; Tobias Junt; Zoe Waibler; Reinhold Forster; Ulrich Kalinke
Journal:  Blood       Date:  2006-07-25       Impact factor: 22.113

7.  CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion.

Authors:  J T Harty; R D Schreiber; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.

Authors:  Theodore Oliphant; Michael Engle; Grant E Nybakken; Chris Doane; Syd Johnson; Ling Huang; Sergey Gorlatov; Erin Mehlhop; Anantha Marri; Kyung Min Chung; Gregory D Ebel; Laura D Kramer; Daved H Fremont; Michael S Diamond
Journal:  Nat Med       Date:  2005-04-24       Impact factor: 53.440

9.  Comparative genomics of Clostridium bolteae and Clostridium clostridioforme reveals species-specific genomic properties and numerous putative antibiotic resistance determinants.

Authors:  Pierre Dehoux; Jean Christophe Marvaud; Amr Abouelleil; Ashlee M Earl; Thierry Lambert; Catherine Dauga
Journal:  BMC Genomics       Date:  2016-10-21       Impact factor: 3.969

10.  Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity.

Authors:  James T Earnest; Katherine Basore; Vicky Roy; Adam L Bailey; David Wang; Galit Alter; Daved H Fremont; Michael S Diamond
Journal:  J Exp Med       Date:  2019-07-23       Impact factor: 14.307

View more
  32 in total

1.  Homeostatic interferon-lambda response to bacterial microbiota stimulates preemptive antiviral defense within discrete pockets of intestinal epithelium.

Authors:  Jacob A Van Winkle; Stefan T Peterson; Elizabeth A Kennedy; Michael J Wheadon; Harshad Ingle; Chandni Desai; Rachel Rodgers; David A Constant; Austin P Wright; Lena Li; Maxim N Artyomov; Sanghyun Lee; Megan T Baldridge; Timothy J Nice
Journal:  Elife       Date:  2022-02-09       Impact factor: 8.140

2.  Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic Acid.

Authors:  Jorge E Vidal; Meagan N Wier; Uriel A Angulo-Zamudio; Erin McDevitt; Ana G Jop Vidal; Babek Alibayov; Anna Scasny; Sandy M Wong; Brian J Akerley; Larry S McDaniel
Journal:  Infect Immun       Date:  2021-09-20       Impact factor: 3.441

3.  The intestinal microbial metabolite nicotinamide n-oxide prevents herpes simplex encephalitis via activating mitophagy in microglia.

Authors:  Feng Li; Yiliang Wang; Xiaowei Song; Zhaoyang Wang; Jiaoyan Jia; Shurong Qing; Lianzhou Huang; Yuan Wang; Shuai Wang; Zhe Ren; Kai Zheng; Yifei Wang
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 4.  Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer.

Authors:  Alyssa Schledwitz; Guofeng Xie; Jean-Pierre Raufman
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

5.  Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation.

Authors:  Ta-Chiang Liu; Justin T Kern; Umang Jain; Naomi M Sonnek; Shanshan Xiong; Katherine F Simpson; Kelli L VanDussen; Emma S Winkler; Talin Haritunians; Atika Malique; Qiuhe Lu; Yo Sasaki; Chad Storer; Michael S Diamond; Richard D Head; Dermot P B McGovern; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2021-05-18       Impact factor: 31.316

6.  BSH-TRAP: Bile salt hydrolase tagging and retrieval with activity-based probes.

Authors:  Bibudha Parasar; Pamela V Chang
Journal:  Methods Enzymol       Date:  2021-12-31       Impact factor: 1.682

7.  Perturbation of Alphavirus and Flavivirus Infectivity by Components of the Bacterial Cell Wall.

Authors:  Lana Langendries; Sofie Jacobs; Rana Abdelnabi; Sam Verwimp; Suzanne Kaptein; Pieter Baatsen; Lieve Van Mellaert; Leen Delang
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

Review 8.  The influence of microbiota-derived metabolites on viral infections.

Authors:  Ajisha Alwin; Stephanie M Karst
Journal:  Curr Opin Virol       Date:  2021-06-16       Impact factor: 7.121

Review 9.  Microbial metabolites: cause or consequence in gastrointestinal disease?

Authors:  Serge Alain Fobofou; Tor Savidge
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-03-10       Impact factor: 4.871

Review 10.  Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease.

Authors:  Eileen Haring; Robert Zeiser; Petya Apostolova
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.